Geoffrey Porges
Stock Analyst at SVB Leerink
(0.86)
# 2,819
Out of 4,412 analysts
112
Total ratings
41.86%
Success rate
-7.73%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintains: Market Perform | n/a | $25.40 | - | 10 | Dec 15, 2021 | |
| RDUS Radius Health | Maintains: Market Perform | n/a | $17.90 | - | 9 | Dec 9, 2021 | |
| RCUS Arcus Biosciences | Maintains: Outperform | n/a | $15.55 | - | 6 | Nov 18, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | n/a | $883.20 | - | 11 | Nov 5, 2021 | |
| HALO Halozyme Therapeutics | Maintains: Outperform | n/a | $38.57 | - | 2 | Nov 3, 2021 | |
| AMGN Amgen | Maintains: Market Perform | n/a | $269.98 | - | 10 | Nov 3, 2021 | |
| ABBV AbbVie | Maintains: Outperform | n/a | $159.62 | - | 12 | Nov 1, 2021 | |
| ROIV Roivant Sciences | Initiates: Outperform | n/a | $11.03 | - | 1 | Nov 1, 2021 | |
| GILD Gilead Sciences | Maintains: Outperform | n/a | $65.42 | - | 11 | Oct 29, 2021 | |
| SNY Sanofi | Upgrades: Outperform | n/a | $49.13 | - | 2 | Sep 27, 2021 | |
| TBPH Theravance Biopharma | Maintains: Outperform | n/a | $9.12 | - | 9 | Sep 16, 2021 | |
| FGEN FibroGen | Maintains: Outperform | n/a | $1.04 | - | 5 | Aug 10, 2021 | |
| TBIO Telesis Bio | Maintains: Market Perform | n/a | $0.32 | - | 6 | Aug 3, 2021 | |
| VRTX Vertex Pharmaceuticals | Maintains: Underperform | n/a | $397.48 | - | 8 | Jul 30, 2021 | |
| MOR MorphoSys AG | Upgrades: Outperform | n/a | $18.04 | - | 2 | Jun 3, 2021 | |
| ASMB Assembly Biosciences | Maintains: Market Perform | $96 → $84 | $12.65 | +564.03% | 3 | May 10, 2021 | |
| GSK GSK | Downgrades: Market Perform | n/a | $41.11 | - | 1 | Mar 23, 2021 | |
| OPT Opthea | Initiates: Outperform | n/a | $3.40 | - | 1 | Nov 11, 2020 | |
| WVE Wave Life Sciences | Initiates: Outperform | n/a | $4.66 | - | 2 | Nov 28, 2018 | |
| BIIB Biogen | Downgrades: Market Perform | n/a | $208.90 | - | 1 | Mar 16, 2017 |
Pfizer
Dec 15, 2021
Maintains: Market Perform
Price Target: n/a
Current: $25.40
Upside: -
Radius Health
Dec 9, 2021
Maintains: Market Perform
Price Target: n/a
Current: $17.90
Upside: -
Arcus Biosciences
Nov 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $15.55
Upside: -
Regeneron Pharmaceuticals
Nov 5, 2021
Maintains: Outperform
Price Target: n/a
Current: $883.20
Upside: -
Halozyme Therapeutics
Nov 3, 2021
Maintains: Outperform
Price Target: n/a
Current: $38.57
Upside: -
Amgen
Nov 3, 2021
Maintains: Market Perform
Price Target: n/a
Current: $269.98
Upside: -
AbbVie
Nov 1, 2021
Maintains: Outperform
Price Target: n/a
Current: $159.62
Upside: -
Roivant Sciences
Nov 1, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.03
Upside: -
Gilead Sciences
Oct 29, 2021
Maintains: Outperform
Price Target: n/a
Current: $65.42
Upside: -
Sanofi
Sep 27, 2021
Upgrades: Outperform
Price Target: n/a
Current: $49.13
Upside: -
Theravance Biopharma
Sep 16, 2021
Maintains: Outperform
Price Target: n/a
Current: $9.12
Upside: -
FibroGen
Aug 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $1.04
Upside: -
Telesis Bio
Aug 3, 2021
Maintains: Market Perform
Price Target: n/a
Current: $0.32
Upside: -
Vertex Pharmaceuticals
Jul 30, 2021
Maintains: Underperform
Price Target: n/a
Current: $397.48
Upside: -
MorphoSys AG
Jun 3, 2021
Upgrades: Outperform
Price Target: n/a
Current: $18.04
Upside: -
Assembly Biosciences
May 10, 2021
Maintains: Market Perform
Price Target: $96 → $84
Current: $12.65
Upside: +564.03%
GSK
Mar 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $41.11
Upside: -
Opthea
Nov 11, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.40
Upside: -
Wave Life Sciences
Nov 28, 2018
Initiates: Outperform
Price Target: n/a
Current: $4.66
Upside: -
Biogen
Mar 16, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $208.90
Upside: -